Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Pradeep Pushparaj Selvadoss, Jayshree Nellore, Malathy Balaraman Ravindrran & Uma Sekar. (2018) Novel pyochelin-based PEGylated liposomes for enhanced delivery of antibiotics against resistant clinical isolates of Pseudomonas aeruginosa. Artificial Cells, Nanomedicine, and Biotechnology 46:8, pages 2043-2053.
Read now
Read now
Shirui Tan, Changpei Gan, Rongpeng Li, Yan Ye, Shuang Zhang, Xu Wu, Yi Yan Yang, Weimin Fan & Min Wu. (2015) A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model. International Journal of Nanomedicine 10, pages 1045-1059.
Read now
Read now
Nafsika H Georgopapadakou. (2014) Prospects for new antibacterials: can we do better?. Expert Opinion on Investigational Drugs 23:2, pages 145-148.
Read now
Read now
Gregory D Cuny. (2009) A new class of UDP-3-O-(R-3-hydroxymyristol)-N-acetylglucosamine deacetylase (LpxC) inhibitors for the treatment of Gram-negative infections: PCT application WO 2008027466. Expert Opinion on Therapeutic Patents 19:6, pages 893-899.
Read now
Read now
Articles from other publishers (33)
Shanfang Fang, Yuan-Ye Dang, Haizhou Li, Hongxia Li, Jiayong Liu, Rongcui Zhong, Yongzhi Chen, Shouping Liu & Shuimu Lin. (2022) Membrane-Active Antibacterial Agents Based on Calix[4]arene Derivatives: Synthesis and Biological Evaluation. Frontiers in Chemistry 10.
Crossref
Crossref
Fuqing Huang, Kunling Teng, Yayong Liu, Yanhong Cao, Tianwei Wang, Cui Ma, Jie Zhang & Jin Zhong. (2021) Bacteriocins: Potential for Human Health. Oxidative Medicine and Cellular Longevity 2021, pages 1-17.
Crossref
Crossref
Clarisse Roblin, Steve Chiumento, Cédric Jacqueline, Eric Pinloche, Cendrine Nicoletti, Hamza Olleik, Elise Courvoisier-Dezord, Agnès Amouric, Christian Basset, Louis Dru, Marie Ollivier, Aurélie Bogey-Lambert, Nicolas Vidal, Mohamed Atta, Marc Maresca, Estelle Devillard, Victor Duarte, Josette Perrier & Mickael Lafond. (2021) The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health. International Journal of Molecular Sciences 22:6, pages 3253.
Crossref
Crossref
Xinyi Zhu, Peizhen Li, Changrui Qian, Hongmao Liu, Hailong Lin, Xueya Zhang, Qiaoling Li, Junwan Lu, Xi Lin, Teng Xu, Hailin Zhang, Yunliang Hu, Qiyu Bao & Kewei Li. (2020)
Prevalence of Aminoglycoside Resistance Genes and Molecular Characterization of a Novel Gene,
aac(3)-IIg
, among Clinical Isolates of the Enterobacter cloacae Complex from a Chinese Teaching Hospital
. Antimicrobial Agents and Chemotherapy 64:9.
Crossref
Crossref
Steve Chiumento, Clarisse Roblin, Sylvie Kieffer-Jaquinod, Sybille Tachon, Chloé LeprètreChristian BassetDwi Aditiyarini, Hamza Olleik, Cendrine NicolettiOlivier BornetOlga IranzoMarc Maresca, Renaud Hardré, Michel FonsThierry GiardinaEstelle DevillardFrançoise GuerlesquinYohann Couté, Mohamed AttaJosette PerrierMickael Lafond & Victor Duarte. (2019) Ruminococcin C, a promising antibiotic produced by a human gut symbiont. Science Advances 5:9.
Crossref
Crossref
Sohaila Andleeb, Imtiaz‐ud‐Din, Muhammad Khawar Rauf, Syed Sikander Azam, Ihsan‐ul Haq, Muhammad Nawaz Tahir & Sajjad Ahmad. (2019) Bioactive Heteroleptic Bismuth(V) Complexes: Synthesis, Structural Analysis and Binding Pattern Validation. Applied Organometallic Chemistry 33:9.
Crossref
Crossref
Andrew J. Tague, Papanin Putsathit, Katherine A. Hammer, Steven M. Wales, Daniel R. Knight, Thomas V. Riley, Paul A. Keller & Stephen G. Pyne. (2019) Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies. European Journal of Medicinal Chemistry 168, pages 386-404.
Crossref
Crossref
Sinosh Skariyachan. 2017. Recent advances in Applied Microbiology. Recent advances in Applied Microbiology
109
132
.
Chenliang Zhou, Xiaobing Chen, Liwen Wu & Jing Qu. (2016) Distribution of drug-resistant bacteria and rational use of clinical antimicrobial agents. Experimental and Therapeutic Medicine.
Crossref
Crossref
Chuanming Zhang, Xiuyu Xu, Shuli Pu, Shifeng Huang, Jide Sun, Shuangshuang Yang & Liping Zhang. (2014) Characterization of carbapenemases, extended spectrum β-lactamases, quinolone resistance and aminoglycoside resistance determinants in carbapenem-non-susceptible Escherichia coli from a teaching hospital in Chongqing, Southwest China. Infection, Genetics and Evolution 27, pages 271-276.
Crossref
Crossref
Abdulrahman A. Al-Sultan, Marzook M. Al-Eknah, Abdullah M. Al-Dougym & Elsayed Aboulmagd. (2014) Detection of Klebsiella pneumoniae, Pseudomonas aeruginosa and ESBL Producing Escherichia coli Associated with Ovarian Hydrobursitis Syndrome in Female Camels (Camelus dromedarus). Asian Journal of Animal and Veterinary Advances 9:8, pages 499-505.
Crossref
Crossref
Arshad Islam, Jeferson Da Silva, Filipe Berbet, Sydnei da Silva, Bernardo Rodrigues, Heloisa Beraldo, Maria Melo, Frédéric Frézard & Cynthia Demicheli. (2014) Novel Triphenylantimony(V) and Triphenylbismuth(V) Complexes with Benzoic Acid Derivatives: Structural Characterization, in Vitro Antileishmanial and Antibacterial Activities and Cytotoxicity against Macrophages. Molecules 19:5, pages 6009-6030.
Crossref
Crossref
Susanna Nybond, Matti Karp & P?ivi Tammela. (2013) Antimicrobial assay optimization and validation for HTS in 384-well format using a bioluminescent E. coli K-12 strain. European Journal of Pharmaceutical Sciences 49:4, pages 782-789.
Crossref
Crossref
Viviane F Cardozo, Admilton G Oliveira, Erick K Nishio, Marcia RE Perugini, Célia GTJ Andrade, Wanderley D Silveira, Nelson Durán, Galdino Andrade, Renata KT Kobayashi & Gerson Nakazato. (2013) Antibacterial activity of extracellular compounds produced by a Pseudomonas strain against methicillin-resistant Staphylococcus aureus (MRSA) strains. Annals of Clinical Microbiology and Antimicrobials 12:1.
Crossref
Crossref
H P Rang, M M Dale, J M Ritter, R J Flower & G Henderson. 2012. Rang & Dale's Pharmacology. Rang & Dale's Pharmacology
622
637
.
Sandeep Putty, Aman Rai, Darshan Jamindar, Paul Pagano, Cheryl L. Quinn, Takehiko Mima, Herbert P. Schweizer & William G. Gutheil. (2011) Characterization of d-boroAla as a Novel Broad-Spectrum Antibacterial Agent Targeting d-Ala-d-Ala Ligase. Chemical Biology & Drug Design 78:5, pages 757-763.
Crossref
Crossref
Selvam Chitra, Nidhin Paul, Shanmugam Muthusubramanian, Paramasivam Manisankar, Perumal Yogeeswari & Dharmarajan Sriram. (2011) A facile synthesis of carbocycle-fused mono and bis-1,2,3-selenadiazoles and their antimicrobial and antimycobacterial studies. European Journal of Medicinal Chemistry 46:11, pages 5465-5472.
Crossref
Crossref
Laura Freire-Moran, Bo Aronsson, Chris Manz, Inge C. Gyssens, Anthony D. So, Dominique L. Monnet & Otto Cars. (2011) Critical shortage of new antibiotics in development against multidrug-resistant bacteria—Time to react is now. Drug Resistance Updates 14:2, pages 118-124.
Crossref
Crossref
Lynn L. Silver. (2011) Challenges of Antibacterial Discovery. Clinical Microbiology Reviews 24:1, pages 71-109.
Crossref
Crossref
Frank-Rainer Schmidt. 2011. Industrial Applications. Industrial Applications
101
121
.
Keith S. Kaye, Paul Auwaerter, John A. Bosso, Nathan C. Dean, Gary V. Doern, Michael B. Kays, Jason M. Pogue, David J. Ritchie & Brian Wispelwey. (2010) Strategies to Address Appropriate Fluoroquinolone Use in the Hospital. Hospital Pharmacy 45:11, pages 844-853.
Crossref
Crossref
Lee S. Engel. (2010) The Dilemma of Multidrug-Resistant Gram-Negative Bacteria. The American Journal of the Medical Sciences 340:3, pages 232-237.
Crossref
Crossref
Brad Moriyama, Stacey A Henning, Richard Childs, Steven M Holland, Victoria L Anderson, John C Morris, Wyndham H Wilson, George L Drusano & Thomas J Walsh. (2010)
High-Dose Continuous Infusion β-Lactam Antibiotics for the Treatment of Resistant
Pseudomonas Aeruginosa
Infections in Immunocompromised Patients
. Annals of Pharmacotherapy 44:5, pages 929-935.
Crossref
Crossref
Karim Makdoumi, Anders Bäckman, Jes Mortensen & Sven Crafoord. (2009) Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA). Graefe's Archive for Clinical and Experimental Ophthalmology 248:2, pages 207-212.
Crossref
Crossref
Alfonso J. C. Soler Bistué, Fernando A. Martín, Nicolás Vozza, Hongphuc Ha, Jonathan C. Joaquín, Angeles Zorreguieta & Marcelo E. Tolmasky. (2009)
Inhibition of
aac(6′)-Ib
-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria
. Proceedings of the National Academy of Sciences 106:32, pages 13230-13235.
Crossref
Crossref
Laurent Mamelli, Sylvain Petit, Jacqueline Chevalier, Carmela Giglione, Aurélie Lieutaud, Thierry Meinnel, Isabelle Artaud & Jean-Marie Pagès. (2009) New Antibiotic Molecules: Bypassing the Membrane Barrier of Gram Negative Bacteria Increases the Activity of Peptide Deformylase Inhibitors. PLoS ONE 4:7, pages e6443.
Crossref
Crossref
Brad Moriyama, Stacey A Henning, Melinda M Neuhauser, Robert L Danner & Thomas J Walsh. (2009) Continuous-Infusion β-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria. Annals of Pharmacotherapy 43:7-8, pages 1324-1337.
Crossref
Crossref
Thomas J. Walsh. (2009) Advances and Challenges in Infectious Diseases Supportive Care of Patients With Hematologic Malignancies, Hematopoietic Stem Cell Transplantation, and Severe Aplastic Anemia. Seminars in Hematology 46:3, pages 191-197.
Crossref
Crossref
Ursula Theuretzbacher. (2009) Future antibiotics scenarios: is the tide starting to turn?. International Journal of Antimicrobial Agents 34:1, pages 15-20.
Crossref
Crossref
Céline Vidaillac, Steve N. Leonard, Helio S. Sader, Ronald N. Jones & Michael J. Rybak. (2009)
In Vitro Activity of Ceftaroline Alone and in Combination against Clinical Isolates of Resistant Gram-Negative Pathogens, Including β-Lactamase-Producing
Enterobacteriaceae
and
Pseudomonas aeruginosa
. Antimicrobial Agents and Chemotherapy 53:6, pages 2360-2366.
Crossref
Crossref
Knut Ohlsen, Martin Eckart, Ulrich Dobrindt, Heike Bruhn & Jörg Hacker. 2009. Antiparasitic and Antibacterial Drug Discovery. Antiparasitic and Antibacterial Drug Discovery
373
413
.
D. M. Livermore & P. M. Tulkens. (2008) Temocillin revived. Journal of Antimicrobial Chemotherapy 63:2, pages 243-245.
Crossref
Crossref
Knut Ohlsen, Gudrun Dandekar, Roland Schwarz & Thomas Dandekar. (2008) New trends in pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics 9:11, pages 1711-1723.
Crossref
Crossref